Journal of Clinical Microbiology · 2015 · 69 citations · 19 references
Veterinary MedicineInfectious DiseasesMicrobiologyDiagnostic MicrobiologyInfection PreventionMedical MicrobiologyInfectious Disease ScreeningSexually Transmitted Infection CareSexually Transmitted Infection DiagnosticsSexually Transmitted Infection EpidemiologySexually Transmitted Infection PreventionSexually Transmitted InfectionsNucleic Acid AmplificationNucleic Acid Amplification DiagnosticsPharyngeal Specimen TestingRectal Specimen TestingSexually Transmitted Infection AssessmentSexually Transmitted Infection DiagnosisUrogenital Specimen TestingVaginal Swab Testing
Triple-site testing (using pharyngeal, rectal, and urethral/first-void urine samples) for Neisseria gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification tests detects greater numbers of infections among men who have sex with men (MSM). However, triple-site testing represents a cost pressure for services. MSM over 18 years of age were eligible if they requested testing for sexually transmitted infections (STIs), reported recent sexual contact with either C. trachomatis or N. gonorrhoeae, or had symptoms of an STI. Each patient underwent standard-of-care (SOC) triple-site testing, and swabs were taken to form a pooled sample (PS) (pharyngeal, rectal, and urine specimens). The PS was created using two methods during different periods at one clinic, but we analyzed the data in combination because the sensitivity of the two methods did not differ significantly for C. trachomatis (P = 0.774) or N. gonorrhoeae (P = 0.163). The sensitivity of PS testing (92%) was slightly lower than that of SOC testing (96%) for detecting C. trachomatis (P = 0.167). For N. gonorrhoeae, the sensitivity of PS testing (90%) was significantly lower than that of SOC testing (99%) (P < 0.001). When pharynx-only infections were excluded, the sensitivity of PS testing to detect N. gonorrhoeae infections increased to 94%. Our findings show that pooling of self-taken samples could be an effective and cost-saving method, with high negative predictive values. (Interim results of this study were presented at the BASHH 2013 summer meeting.).
19
Akke K. van der Bij, Joke Spaargaren, Servaas A. Morré et al. · Clinical Infectious Diseases · 2005 · 183 citations · Full text
HIV and sexually transmitted diseases: lethal synergy.
Myron S. Cohen · PubMed · 2004 · 151 citations